C
CellX Biosolutions
Sustainable chemical waste treatment using high-performance bacteria for industrial pollution solutions
About CellX Biosolutions
CellX operates in the environmental biotechnology sector, focusing on sustainable treatment of chemical waste through the discovery and application of high-performance bacteria. The company targets industries dealing with chemical pollution, offering tailored biological solutions to degrade specific industrial chemicals, including PFAS, pharmaceuticals, and microplastics. CellX's business model involves identifying and optimizing bacterial communities to meet clients' unique waste treatment needs, ensuring scalability and effectiveness. Revenue is generated by providing these customized bacterial solutions in collaboration with industrial partners. The company leverages deep biodiversity to address significant pollution challenges, positioning itself as a key player in the sustainable waste management market.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2024
- Headquarters
- Zurich, Switzerland
- Employees
- 15
- Open positions
- None listed
- Dealroom signal
- 79.9/100
- Industry
- Energy
- Sub-industry
- Waste Solution
- Sector
- Energy, Spinout, Sustainable Development Goals, Climate Tech, Woman Founder, PFAS, DT and LS, science-based, Swiss DT Climate & Energy
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Feb 2025 | $0 | — | Stadt Zürich | ↗ |
| SEED✓Equity / VC | Feb 2025 | $1.6M | $6.2M | Business Angels Switzerland · Positron ventures · Marcello Campanelli · Venture Kick | ↗ |
Growth signals
Latest recorded traffic for CellX Biosolutions is 6.1K monthly website visits, up 1748.5% over the last three months. CellX Biosolutions's team grew 400% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
Venture Kick
Positron ventures
Business Angels Switzerland- MCMarcello Campanelli
- IMIan Metcalfe
Kickfund
Series B and later1 investor entered at this stage
Stadt Zürich
Other known investors3 additional known investors
ETH Zurich
MassChallenge
BlueLion
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about CellX Biosolutions on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CellX Biosolutions’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







